CVM compared with NRSN: revenue, margins and what each company keeps, and the suppliers and customers both name

CVMCEL SCI Corp

Mkt capRevenueRevenue

NRSNNeuroSense Therapeutics Ltd.

Mkt capRevenueRevenue

Compare

CVMCEL SCI Corp

NRSNNeuroSense Therapeutics Ltd.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

CVM, solidNRSN, dashed

Supply-chain overlap

Revenue flow

CVM: latest quarter not drawable. NRSN: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CVM 3

TEVATeva Pharmaceutical Industriescustomer

—Byron BioPharmaunlistedcustomer

—Orient Europharmaunlistedcustomer

Shared 0

No disclosed counterparties: NRSN.

Only NRSN 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

CVMCEL SCI Corp

1.39▼−7.38%· post 1.40

Mkt cap$24.3M

NRSNNeuroSense Therapeutics Ltd.

2.01▼−5.63%· post 2.01

ClosedOct 30 '26

Mkt cap$2.5M

Compare

ClosedOct 30 '26

CVMCEL SCI Corp

NRSNNeuroSense Therapeutics Ltd.

1.39▼−7.38%post 1.40

Price

2.01▼−5.63%post 2.01

$24.3M

Mkt cap

$2.5M

CVM1.39▼−7.38%vsNRSN2.01▼−5.63%ClosedOct 30 '26